Key Insights

Highlights

Success Rate

86% trial completion

Published Results

31 trials with published results (11%)

Research Maturity

152 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.3%

24 terminated out of 290 trials

Success Rate

86.4%

-0.2% vs benchmark

Late-Stage Pipeline

4%

13 trials in Phase 3/4

Results Transparency

20%

31 of 152 completed with results

Key Signals

31 with results86% success24 terminated

Data Visualizations

Phase Distribution

212Total
Not Applicable (165)
Early P 1 (3)
P 1 (11)
P 2 (20)
P 3 (8)
P 4 (5)

Trial Status

Completed152
Recruiting44
Unknown36
Terminated24
Active Not Recruiting13
Enrolling By Invitation8

Trial Success Rate

86.4%

Benchmark: 86.6%

Based on 152 completed trials

Clinical Trials (290)

Showing 20 of 20 trials
NCT07855627RecruitingPrimary

Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements

NCT06989099Phase 2RecruitingPrimary

Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

NCT03248310RecruitingPrimary

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

NCT07838857Not ApplicableNot Yet RecruitingPrimary

Evaluation of Adherence to Rehabilitation: Autonomous and Guided, in the Observation and Treatment Response of Head and Neck Lymphedema in Neoplasms During Radiotherapy

NCT07558317Not ApplicableRecruitingPrimary

The Effect of Resistance Exercise in Patients With Lower Limb Lymphedema (the LymphEx Study)

NCT05056207Not ApplicableActive Not RecruitingPrimary

PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema

NCT06494111Phase 2RecruitingPrimary

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

NCT06725030Recruiting

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

NCT07794904Not ApplicableActive Not Recruiting

Effectiveness of a Tele-Rehabilitation-Based Exercise and Self-Lymphatic Drainage Program Supported by Self-Management for Breast Cancer-Related Lymphedema

NCT06228937RecruitingPrimary

Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis

NCT05962827Not ApplicableRecruitingPrimary

Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY

NCT02250456Terminated

AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)

NCT07448467Not ApplicableCompletedPrimary

Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema.

NCT05366699Not ApplicableRecruiting

LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy

NCT07744906Completed

Relationship Between Balance and Body Awareness in Lymphedema Patients

NCT06912763Phase 2Recruiting

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

NCT07708662Not ApplicableRecruiting

Boosted Compression for Lower Limb Chronic Edema

NCT05142800RecruitingPrimary

Screening For BCRL In Targeted Therapy For Breast Cancer

NCT07414615Not ApplicableCompletedPrimary

Aerobic Training in Lower Extremity Lymphedema

NCT07311876Not ApplicableRecruitingPrimary

Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani

Scroll to load more

Research Network

Activity Timeline